Advanced Biomed Inc. (ADVB)

Advanced Biomed Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	2.53	4.78	0.07
Cash & Cash Equivalents	2.53	4.78	0.07
Cash Growth	-	7156.86%	-
Other Current Assets	0.46	0.22	0.85
Total Current Assets	2.99	5.01	0.91
Property, Plant & Equipment	-	0.78	0.09
Goodwill and Intangibles	-	0.85	0.01
Other Long-Term Assets	-	0.07	0
Total Long-Term Assets	-	1.71	0.09
Total Assets	-	6.71	1.01
Accounts Payable	-	2.75	0.02
Current Debt	-	0.24	0.01
Other Current Liabilities	1.96	0	0
Total Current Liabilities	1.96	2.99	0.03
Long-Term Debt	-	0.23	0
Total Long-Term Liabilities	-	0.23	0
Total Liabilities	-	3.22	0.03
Total Debt	0.3	0.47	0.01
Debt Growth	-	6578.08%	-
Retained Earnings	-	-9.46	-5.43
Comprehensive Income	-	0.27	-0.18
Shareholders' Equity	2.39	3.49	0.98
Net Cash / Debt	2.23	4.31	0.06
Net Cash / Debt Growth	-	7225.85%	-
Working Capital	1.03	2.02	0.89

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).